Is PT-141 FDA-approved
Carter BZ, Mak PY, Mak DH, Shi Y, Qiu Y, Kornblau S, McQueen T, Weng D, Burns J, Andreeff M
doi: 10.1016/j.jfca.2014.12.015 113 JamilianHJamilianMSamimiMAfshar EbrahimiFRahimiMBahmaniFet al
Faster to produce, easier to take, and precise in dosing ODFs deliver exactly what patients and the market demand
Emerging Science on Dopamine Pathways The latest research, some of which has just been published in late 2025 and early 2026, is beginning to explore how GLP-1s interact with the brain's reward system
( The fact that aberrations in GABA neurotransmission are associated with a number of neurological diseases including epilepsy [see Ref